| Product Code: ETC11581518 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Chemotherapy-Induced Nauvomiting Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, 2021 & 2031F |
3.3 India Chemotherapy-Induced Nauvomiting Market - Industry Life Cycle |
3.4 India Chemotherapy-Induced Nauvomiting Market - Porter's Five Forces |
3.5 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Chemotherapy-Induced Nauvomiting Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing adoption of chemotherapy treatments |
4.2.3 Rising awareness about the importance of managing chemotherapy-induced nausea and vomiting |
4.3 Market Restraints |
4.3.1 High cost associated with anti-nausea medications |
4.3.2 Side effects and limited efficacy of current nausea and vomiting treatments |
5 India Chemotherapy-Induced Nauvomiting Market Trends |
6 India Chemotherapy-Induced Nauvomiting Market, By Types |
6.1 India Chemotherapy-Induced Nauvomiting Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Serotonin (5-HT3) Receptor Antagonists, 2021 - 2031F |
6.1.4 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Neurokinin-1 (NK-1) Receptor Antagonists, 2021 - 2031F |
6.1.5 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Cannabinoids, 2021 - 2031F |
6.1.6 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Non-Pharmacological Therapies, 2021 - 2031F |
6.2 India Chemotherapy-Induced Nauvomiting Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Neurotransmitter Blockade, 2021 - 2031F |
6.2.3 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By CNS Pathway Modulation, 2021 - 2031F |
6.2.4 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Endocannabinoid System Modulation, 2021 - 2031F |
6.2.5 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Acupressure & Aromatherapy, 2021 - 2031F |
6.3 India Chemotherapy-Induced Nauvomiting Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Oncology Patients, 2021 - 2031F |
6.3.3 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.3.4 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Cancer Survivors, 2021 - 2031F |
6.3.5 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Homecare & Alternative Medicine Centers, 2021 - 2031F |
6.4 India Chemotherapy-Induced Nauvomiting Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Delayed CINV Management, 2021 - 2031F |
6.4.3 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Prevention of Nausea and Vomiting, 2021 - 2031F |
6.4.4 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Symptom Relief, 2021 - 2031F |
6.4.5 India Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Complementary CINV Management, 2021 - 2031F |
7 India Chemotherapy-Induced Nauvomiting Market Import-Export Trade Statistics |
7.1 India Chemotherapy-Induced Nauvomiting Market Export to Major Countries |
7.2 India Chemotherapy-Induced Nauvomiting Market Imports from Major Countries |
8 India Chemotherapy-Induced Nauvomiting Market Key Performance Indicators |
8.1 Patient satisfaction with nausea and vomiting management |
8.2 Number of clinical trials focused on developing new anti-nausea drugs |
8.3 Rate of adoption of evidence-based guidelines for managing chemotherapy-induced nausea and vomiting |
9 India Chemotherapy-Induced Nauvomiting Market - Opportunity Assessment |
9.1 India Chemotherapy-Induced Nauvomiting Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Chemotherapy-Induced Nauvomiting Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 India Chemotherapy-Induced Nauvomiting Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 India Chemotherapy-Induced Nauvomiting Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Chemotherapy-Induced Nauvomiting Market - Competitive Landscape |
10.1 India Chemotherapy-Induced Nauvomiting Market Revenue Share, By Companies, 2024 |
10.2 India Chemotherapy-Induced Nauvomiting Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here